Compare Davita Inc (DVA) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Otis Worldwide Corp — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Otis Worldwide Corp trades at $73.45 (market cap $27.74B). The key difference: Otis Worldwide Corp is far larger — about 2.4× Davita Inc's market cap, and Otis Worldwide Corp pays a 2.42% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | OTIS | |
|---|---|---|
Market Cap | $11.72B | $27.74B |
Sector | Health | Industrials |
52-Week High | $240.96 | $93.62 |
52-Week Low | $103.87 | $69.34 |
Enterprise Value | $24.44B | $35.77B |
Dividend Yield | — | 2.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Otis Worldwide (OTIS) trades at $73.99, up 0.22% with a bullish technical signal. The company maintains stable revenue around $14.4B but faces margin pressure despite strong service segment growth. Recent Q2 2026 earnings beat estimates but included guidance cuts, reflecting ongoing challenges in new equipment demand. Analyst consensus remains divided with a $92.50 price target suggesting 25% upside potential.
The investment case hinges on service segment momentum offsetting equipment weakness, but margin compression and elevated debt levels pose risks. With mixed analyst ratings and recent institutional selling, the stock offers value if service margins improve, though execution risks remain elevated in the current economic environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
